Jonathan Ticku

Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab

Bahar Saberzadeh-Ardestani, Jeremy Jones, Joleen M. Hubbard et al. · JAMA Network Open · 2023 · 46 citations · Full text

Blockade of MGMT Expression by O6 Benzyl Guanine Leads to Inhibition of Pancreatic Cancer Growth and Induction of Apoptosis

Santhi D. Konduri, Jonathan Ticku, George C. Bobustuc et al. · Clinical Cancer Research · 2009 · 33 citations · Full text

Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021

Joshua C. Pritchett, Bijan J. Borah, Ruchita Dholakia et al. · JCO Oncology Practice · 2023 · 24 citations · Full text

Acute lymphoblastic leukemia in pregnancy: a case report with literature review

Jonathan Ticku, Shilpa Oberoi, Sarah Friend et al. · Therapeutic Advances in Hematology · 2013 · 22 citations · Full text

Hematological Malignancy, Abortion, Weeks Gestation +15

Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting

Bahar Saberzadeh-Ardestani, Jeremy Jones, Robert R. McWilliams et al. · European Journal of Cancer · 2023 · 18 citations

Surgical Oncology, Medicine, Cancer Management +9